Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZhejiang Yong. Regulatory News (YTT)

Share Price Information for Zhejiang Yong. (YTT)

Share Price is delayed by 15 minutes
Get Live Data
14.40    0.00 (0.00%)
Bid:
16.20
Ask:
16.80
Spread: 0.60 (3.704%)
Market Cap: $2.66b
YTT Live PriceLast checked at - London Stock Exchange

Intraday Zhejiang Yong. Share Chart

  • This share is an international stock.

Preliminary Estimation for the Interim Results

14 Jul 2023 09:23

RNS Number : 0652G
Zhejiang Yongtai Technology Co Ltd
14 July 2023
 

ZHEJIANG YONGTAI TECHNOLOGY CO., LTD.

(GDR under the symbol: "YYT")

(a joint stock company established under the laws of the People's Republic of China with limited liability)

Preliminary Estimation for the Interim Results of 2023

The Company and all members of the Board of Directors confirm that all the information contained in this information disclosure is true, accurate and complete and that there is no false and misleading statement or material omission in this information disclosure.

I. Preliminary Results for the Current Period

1. Period for the estimated results: 1 January 2023 to 30 June 2023;

2. Estimated results:

ðLoss ðTurn loss into profit 

ðIncrease over last year √Decrease over last year

Item

Current reporting period

Corresponding period last year

Net profit attributable to

the shareholders of the

listed company

Profit: RMB30 million -RMB42 million

Profit: RMB493.6041 million

Decreased by 93.92%-91.49% as compared to the corresponding period last year

Net profit after deducting non-recurring gains and losses

Loss: RMB50 million-RMB38 million

Profit: RMB488.8735 million

Decreased by 110.23%-107.77% as compared to the corresponding period last year

Basic earnings per share

Profit: RMB0.03/share - RMB0.05/share

Profit: RMB0.56/share

II. Communication with Accounting Firm

The financial data related to this preliminary results has not been audited by the accounting firm.

III. Explanation for the Changes in Results

(1) The overall results of this reporting period decreased significantly compared to the corresponding period last year, mainly due to the changes in performance of the Company's lithium battery materials segment. During the reporting period, the main product of the Company's lithium battery materials was lithium hexafluorophosphate. Although the sales quantity of this product increased year on year, the market price fell significantly over the corresponding period last year due to changes in the supply and demand relationship between upstream and downstream in the short term, resulting in a sharp decline in product sales revenue. On the other hand, the market price of lithium carbonate, the upstream raw material, was high at the end of last year and at the beginning of this reporting period, and the inventory of raw materials at the beginning of the period was also relatively high, resulting in a relatively high overall cost of lithium battery materials during the reporting period. Under the dual impact of lower sales prices and higher costs, the gross margin and gross profit of the Company's lithium battery materials segment in the first half of the year decreased significantly compared to the corresponding period last year. At present, the high-priced raw materials at the beginning of the period have been used up.

(2) The impact of non-recurring gains and losses on net profit during this reporting period is approximately RMB80 million, mainly due to the asset disposal gains generated from the demolition and compensation of the properties owned by two subsidiaries in Shanghai.

IV. Other Relevant Explanation

This preliminary result is based on the estimation of the Finance Department of the Company, and the specific financial data is subject to the 2023 interim report to be disclosed by the Company. Investors are kindly advised to make cautious decisions and pay attention to investment risks.

Board of Directors

Zhejiang Yongtai Technology Co., Ltd.

14 July 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKQBKFBKKPOD
12
Date   Source Headline
18th May 202612:08 pmRNSResolution of the 2025 Annual General Meeting
27th Apr 202611:52 amRNS2025 Annual Report
27th Apr 202611:41 amRNS2026 First Quarterly Report
27th Apr 202611:30 amRNSNotice of the 2025 Annual General Meeting
27th Apr 202611:24 amRNS2025 ESG Report
13th Feb 20262:38 pmRNSResumption of Trading of the Company's Stock
6th Feb 202611:07 amRNSTrading Suspension for Asset Acquisition
29th Jan 20268:04 amRNSEstimated Results For The Year 2025
30th Oct 202511:59 amRNSRepurchase & Cancellation Of Restricted Shares
28th Oct 20259:02 amRNS2025 Third Quarterly Report
27th Aug 202510:51 amRNS2025 Semi-Annual Report
21st Aug 202512:13 pmRNSResolution of The Second EGM In 2025
31st Jul 20251:09 pmRNSNotice of the Second EGM in 2025
28th Jul 202511:57 amRNSResolution Of The First EGM In 2025
28th Jul 202511:43 amRNSAnnouncement On Election Of Employee Director
14th Jul 20253:00 pmRNSPreliminary 2025 Interim Results Forecast
11th Jul 20252:35 pmRNSNotice of the First EGM in 2025
19th May 202511:00 amRNSResolution of the 2024 Annual General Meeting
25th Apr 20255:42 pmRNS2024 ESG Report
25th Apr 20255:41 pmRNS2024 ESG Report
25th Apr 20255:33 pmRNS2025 First Quarterly Report
25th Apr 20255:29 pmRNSNotice of the 2024 Annual General Meeting
25th Apr 20255:18 pmRNS2024 Annual Report
20th Jan 20259:24 amRNSEstimated Results For The Year 2024
30th Oct 202410:38 amRNS2024 Third Quarterly Report
13th Sep 202410:46 amRNSAnnouncement of the Third EGM Resolution in 2024
28th Aug 202410:38 amRNS2024 Semi-Annual Report
28th Aug 20249:54 amRNSNotice of the Third EGM in 2024
29th Jul 20247:00 amRNSCompletion of 2024 Incentive Scheme Registration
15th Jul 202411:33 amRNSResolution of the Second EGM in 2024
10th Jul 202410:09 amRNSPreliminary 2024 Interim Results Forecast
28th Jun 202411:58 amRNS2024 Restricted Stock Incentive Plan (Draft)
28th Jun 202411:13 amRNSNotice of the Second EGM in 2024
16th May 202410:38 amRNSResolution of the 2023 Annual General Meeting
25th Apr 20241:59 pmRNS2023 Annual Report
25th Apr 20241:54 pmRNS2024 First Quarterly Report
25th Apr 20241:49 pmRNSNotice of the 2023 Annual General Meeting
25th Apr 20241:26 pmRNSAttached:Proposals to 2023 Annual General Meeting
23rd Feb 20249:03 amRNSResolution of the First EGM in 2024
29th Jan 20249:05 amRNSEstimated Results For The Year 2023
29th Jan 20248:44 amRNSNotice of the First EGM in 2024
11th Dec 20238:53 amRNSAnnouncement: Resolution of 2023 2nd EGM
20th Nov 202310:40 amRNSNotice of the Second EGM in 2023
9th Nov 20238:13 amRNSNotice of the Remaining Number of GDRs
30th Oct 20237:45 amRNSSoon-To-Expire Lock-Up Period of GDR Announcement
27th Oct 20238:42 amRNS2023 Third Quarterly Report
20th Sep 20239:43 amRNSThe first Extraordinary General Meeting in 2023
30th Aug 202310:13 amRNS2023 Semi-Annual Report
30th Aug 20239:58 amRNSThe First Extraordinary General Meeting in 2023
14th Jul 20239:23 amRNSPreliminary Estimation for the Interim Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.